Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. titration
Show results for

Refine by

Titration Articles & Analysis

30 news found

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension and Quillivant ER Chewable Tablet for the Treatment of Attention Deficit Hyperactivity Disorder

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension and Quillivant ER Chewable Tablet for the Treatment of Attention Deficit Hyperactivity Disorder

Many therapies approved to treat ADHD have well-established and significant drawbacks, including early symptom rebound, limited duration of release and efficacy, delayed onset, inability to customize or control titration, and patient difficulty taking the medications (e.g., children unable to swallow a tablet). ...

ByTris Pharma, Inc.


The Importance of Optimal Medical Therapy (OMT) and Collaborative Care

The Importance of Optimal Medical Therapy (OMT) and Collaborative Care

The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...

ByHeart Failure Society of America, Inc. (HFSA)


Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

During the dose-optimization phase, subjects will have weekly visits and will be titrated to doses ranging between 25 mg and 50 mg of CTx-1301. Cingulate is utilizing an ALS, which enables the Company to facilitate repeated assessments over the course of a day to evaluate the onset and duration of efficacy provided by CTx-1301. ...

ByCingulate


MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease

MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease

The GRADUATE Phase 3 program evaluated the safety and efficacy of gantenerumab in people with mild cognitive impairment (MCI) due to Alzheimer’s and mild Alzheimer’s dementia over 27 months. 1,965 study participants across 30 countries were randomized 1:1 to receive gantenerumab or placebo by subcutaneous injection titrated to reach a target dose of 510 mg ...

ByMorphoSys AG


Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery

Creative Diagnostics Introduces Fluorometric Neuraminidase Assay Service for High-throughput Discovery

In further detail, researchers from Creative Diagnostics titrate virus isolates based on neuraminidase activity. Then neuraminidase inhibition assays and antiviral drug activity screening will be performed to determine the 50% drug inhibitory dose. ...

ByCreative Diagnostics


Terumo India Signs a New Strategic Commercial Distribution Partnership with Sensible Medical Innovations

Terumo India Signs a New Strategic Commercial Distribution Partnership with Sensible Medical Innovations

Periodic monitoring through ReDS™ Pro and titration of medicines in heart failure patients can potentially reduce hospitalization rates by 30%. ...

BySensible Medical Innovations Ltd.


Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

Invasive devices, such as pulmonary artery pressure sensors, allow for remote measures of clinical congestion and titration of heart failure therapy, but their widespread use is limited by the need for an invasive procedure, a relatively narrow indication for use in patients, and high cost of implantation. ...

ByBodyport Inc.


Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

Cohort 1 patients started at the lowest dose and were titrated through four increasing doses of INT301. The study groups are blinded to the investigator, patients, and the Intrommune study team. ...

ByIntrommune Therapeutics


Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022

Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022

Details for the oral presentation are as follows: Title: Pemvidutide (ALT-801), a Balanced (1:1) GLP-1/Glucagon Dual Receptor Agonist, Induces Rapid and Marked Weight Loss without the Need for Dose Titration in People with Overweight/Obesity Date/Time: Monday, June 6, 2022 at 4:30 pm CDT About Altimmune Altimmune is a clinical-stage biopharmaceutical company focused on the ...

ByAltimmune Inc.


Obsidian Therapeutics to Present Preclinical Data from cytoDRiVE® Platform at the American Associate of Cancer Research (AACR) Annual Meeting 2022

Obsidian Therapeutics to Present Preclinical Data from cytoDRiVE® Platform at the American Associate of Cancer Research (AACR) Annual Meeting 2022

Further, Obsidian regulates mbIL12 expression using its cytoDRiVE® technology as a titratable and reversible rheostat for on-demand protein activity. Seeking even greater control over mbIL12 levels, Obsidian observes that by adding a novel “modulation hub” that increases the multiplicity of DRDs, the regulation of membrane-bound (mbIL12) greatly improves, leading ...

ByObsidian Therapeutics, Inc.


INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

As previously disclosed, Cohort 1 completed up-titrating to Dose 4 with no significant adverse events. Patients with peanut allergy in Cohort 2 were started at Dose 2 and are being up-titrated through 11 increasing doses of INT301 to determine both a MTD and a safe starting dose. Patients in Cohort 3 are starting at Dose 3 and participants in Cohort 4 are ...

ByIntrommune Therapeutics


Altimmune Announces Initiation Of 48-Week Phase 2 MOMENTUM Trial Of Pemvidutide In Obesity

Altimmune Announces Initiation Of 48-Week Phase 2 MOMENTUM Trial Of Pemvidutide In Obesity

Side effects were mild to moderate, with no serious or severe treatment-emergent adverse events, even without the dose-titration schedules commonly used by other therapeutics in this class. ...

ByAltimmune Inc.


Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

” Saluda has pioneered innovations designed to read, record, and respond to nerves during stimulation and over the last decade has advanced the technology to enable dosing that can be titrated at the microsecond level to maintain and optimize consistent therapy for patients. ...

BySaluda Medical Pty Ltd.


CD Formulation Launches a Full Range of Drug Analysis Services for the Pharmaceutical Industry

CD Formulation Launches a Full Range of Drug Analysis Services for the Pharmaceutical Industry

Here are some of the most widely used techniques in the drug analysis process: high-performance liquid chromatography (HPLC), ultra-high performance liquid chromatography (UPLC), gas chromatography (GC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography/mass spectrometry, LC-MS and LC-MS/MS, atomic absorption spectroscopy (AAS), UV/Vis spectroscopy, Fourier transform infrared ...

ByCD Formulation


Quality control of radiopharmaceuticals

Quality control of radiopharmaceuticals

Furthermore, too high Sn(II) contents can have a detrimental effect on the active organic complex. Compared to iodometric titration, polarography is insensitive to other reducing agents, ensuring an interference-free analysis of stannous tin in the mg/L levels. ...

ByMetrohm AG


Impulse Dynamics Receives FDA Approval to Modify Labeling for Optimizer Smart Medical Devices

Impulse Dynamics Receives FDA Approval to Modify Labeling for Optimizer Smart Medical Devices

Access to CCM therapy would often be delayed to assess atrial fibrillation burden further, provide opportunities to restore sinus rhythm or titrate medication. Previously, the presence of A-fib presented, at the very least, a mental barrier for clinicians and sometimes eliminated CCM from consideration. ...

ByImpulse Dynamics


Ferrous iron in iron sucrose injection

Ferrous iron in iron sucrose injection

Iron sucrose injection is commonly prescribed for iron-deficiency anemia treatment. Ferric iron (iron(III)) and sucrose are the main components of the injection. Due to its medical use, U.S. Pharmacopeia (USP) requires the monitoring of ferrous iron (iron(II)), of which not more than 0.4% should be present. Polarography is the stipulated analysis method. Metrohm Application Note AN-V-127 ...

ByMetrohm AG


CBD For Beginners: Everything you should Know About Cannabidiol

CBD For Beginners: Everything you should Know About Cannabidiol

We often recommend that beginners start with a low dosage and slowly titrate upwards until you feel as though you’ve reached an agreeable amount. ...

ByMedcbdx


Modernizing pharmaceutical assay testing

Modernizing pharmaceutical assay testing

Titration is an important analytical method that is widely used for pharmaceutical assay testing. ...

ByMetrohm AG


Inspire Medical Systems, Inc. Announces FDA Approval and Commercial Launch of New Physician Programmer Platform

Inspire Medical Systems, Inc. Announces FDA Approval and Commercial Launch of New Physician Programmer Platform

First, the new design incorporates guided workflows, which direct clinicians step-by-step through the patient management process from initial Inspire activation, to titration sleep studies, and all the way through long-term patient follow-up visits. ...

ByInspire Medical Systems, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT